Response to Comment on Edelman et al. AUTONOMY: The First Randomized Trial Comparing Two Patient-Driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes. Diabetes Care 2014;37:2132–2140

Steve V. Edelman; Rong Liu; Jennal Johnson; Leonard C. Glass

doi:10.2337/dc14-1900

Response to Comment on Edelman et al. AUTONOMY: The First Randomized Trial Comparing Two Patient-Driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes. Diabetes Care 2014;37:2132–2140

Diabetes Care ◽

10.2337/dc14-1900 ◽

2014 ◽

Vol 37 (12) ◽

pp. e263-e264

Author(s):

Steve V. Edelman ◽

Rong Liu ◽

Jennal Johnson ◽

Leonard C. Glass

Keyword(s):

Type 2 Diabetes ◽

Randomized Trial ◽

Insulin Lispro ◽

Diabetes Care ◽

Prandial Insulin

Download Full-text

Comment on Edelman et al. AUTONOMY: The First Randomized Trial Comparing Two Patient-Driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes. Diabetes Care 2014;37:2132–2140

Diabetes Care ◽

10.2337/dc14-1609 ◽

2014 ◽

Vol 37 (12) ◽

pp. e261-e262 ◽

Cited By ~ 1

Author(s):

Helena W. Rodbard ◽

Boris Karolicki

Keyword(s):

Type 2 Diabetes ◽

Randomized Trial ◽

Insulin Lispro ◽

Diabetes Care ◽

Prandial Insulin

Download Full-text

Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial

Diabetology & Metabolic Syndrome ◽

10.1186/s13098-016-0163-3 ◽

2016 ◽

Vol 8 (1) ◽

Cited By ~ 1

Author(s):

Arturo Rojas ◽

Georgina Sposetti ◽

Jorge L. Gross ◽

Douglas Eugenio Barbieri ◽

Ran Duan ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Latin American ◽

Insulin Lispro ◽

Basal Insulin ◽

Once Daily ◽

Insulin Intensification ◽

Prandial Insulin

Download Full-text

Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: A Latin American subpopulation analysis of a randomized trial

Diabetology & Metabolic Syndrome ◽

10.1186/1758-5996-7-s1-a57 ◽

2015 ◽

Vol 7 (S1) ◽

Author(s):

Douglas Eugenio Barbieri ◽

Ran Duan ◽

Jorge Gross ◽

Bruno Linetzky ◽

Janaina Martins De Lana ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Latin American ◽

Insulin Lispro ◽

Basal Insulin ◽

Once Daily ◽

Insulin Intensification ◽

Prandial Insulin

Download Full-text

AUTONOMY: The First Randomized Trial Comparing Two Patient-Driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes

Diabetes Care ◽

10.2337/dc13-2664 ◽

2014 ◽

Vol 37 (8) ◽

pp. 2132-2140 ◽

Cited By ~ 30

Author(s):

Steve V. Edelman ◽

Rong Liu ◽

Jennal Johnson ◽

Leonard C. Glass

Keyword(s):

Type 2 Diabetes ◽

Randomized Trial ◽

Insulin Lispro ◽

Prandial Insulin

Download Full-text

Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920

Diabetes Care ◽

10.2337/dci19-0067 ◽

2020 ◽

Vol 43 (2) ◽

pp. e30-e31 ◽

Cited By ~ 1

Author(s):

Michael A. Nauck ◽

Eskil Kreiner ◽

Søren Rasmussen ◽

Hans A. Saevereid ◽

John B. Buse

Keyword(s):

Type 2 Diabetes ◽

High Risk ◽

Randomized Trial ◽

Diabetes Care ◽

Cardiovascular Events ◽

Biliary Disease

Download Full-text

Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study

The Lancet ◽

10.1016/s0140-6736(15)60936-9 ◽

2015 ◽

Vol 385 (9982) ◽

pp. 2057-2066 ◽

Cited By ~ 122

Author(s):

Lawrence Blonde ◽

Johan Jendle ◽

Jorge Gross ◽

Vincent Woo ◽

Honghua Jiang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Lispro ◽

Open Label ◽

Phase 3 ◽

Prandial Insulin ◽

Open Label Phase

Download Full-text

Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508-2515

Diabetes Care ◽

10.2337/dc13-er12a ◽

2013 ◽

Vol 36 (12) ◽

pp. 4172-4172 ◽

Cited By ~ 2

Author(s):

G. Schernthaner ◽

J. Gross ◽

J. Rosenstock ◽

M. Guarisco ◽

M. Fu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Randomized Trial ◽

Diabetes Care

Download Full-text

Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887-2894

Diabetes Care ◽

10.2337/dc13-1394 ◽

2013 ◽

Vol 36 (12) ◽

pp. e217-e217

Author(s):

N. Kleefstra ◽

S. J. J. Logtenberg ◽

H. J. G. Bilo

Keyword(s):

Type 2 Diabetes ◽

Blood Glucose ◽

Glycemic Control ◽

Randomized Trial ◽

Diabetes Care ◽

Self Monitoring

Download Full-text

Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy

Diabetes Obesity and Metabolism ◽

10.1111/dom.12705 ◽

2016 ◽

Vol 18 (10) ◽

pp. 999-1005 ◽

Cited By ~ 17

Author(s):

Johan Jendle ◽

Marcia A. Testa ◽

Sherry Martin ◽

Honghua Jiang ◽

Zvonko Milicevic

Keyword(s):

Type 2 Diabetes ◽

Continuous Glucose Monitoring ◽

Insulin Lispro ◽

Receptor Agonist ◽

Glucose Monitoring ◽

Prandial Insulin ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

A Randomized Trial of Step-up Treatment with Premixed Insulin Lispro-50/50 vs. Aspart-70/30 in Patients with Type 2 Diabetes Mellitus

Diabetes Therapy ◽

10.1007/s13300-014-0078-7 ◽

2014 ◽

Vol 5 (2) ◽

pp. 403-413 ◽

Cited By ~ 3

Author(s):

Nozomi Domeki ◽

Mihoko Matsumura ◽

Tsuyoshi Monden ◽

Yuki Nakatani ◽

Yoshimasa Aso

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Randomized Trial ◽

Insulin Lispro ◽

Premixed Insulin

Download Full-text